CIK 0001133869
- Non-accelerated filer
- Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 310-358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2009-01-16 | Strumph Peter M Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +149,148 | 149,148 | ||
| 2008-12-12 | Strumph Peter M Chief Executive Officer | Purchase | +1,000 | $1.00 | $1K | 5,580 |
| 2008-12-12 | Strumph Peter M Chief Executive Officer | Purchase | +2,000 | $0.79 | $2K | 7,580 |
| 2008-12-11 | Strumph Peter M Chief Executive Officer | Purchase | +3,580 | $0.60 | $2K | 4,580 |
| 2008-04-14 | Strumph Peter M Chief Executive Officer | Purchase | +1,000 | $4.70 | $5K | 1,000 |
| 2008-04-14 | Strumph Peter M Chief Executive Officer | Purchase | +200 | $4.70 | $940 | 200 |
| 2008-04-14 | Strumph Peter M Chief Executive Officer | Purchase | +200 | $4.70 | $940 | 200 |
| 2008-03-04 | Strumph Peter M Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +139,008 | 139,008 |
Page 1 of 1 · 8 trades